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ABSTRACT
A simple and rapid high performance liquid chromatographic (HPLC) method was developed to determine the major carotenoids in
human serum. Lutein, b-carotene and lycopene were separated within 20 min using a C18 column and a mobile phase of
methanol/methylene chloride (95:5, v/v) with sample solvent methanol/methylene chloride (45:55, v/v), detection at 476 nm and flow
rate at 0.8 mL/min. A high recovery was achieved with this method, which amounted to 92, 90 and 87% for lutein, b-carotene and
lycopene, respectively, while the detection limit was 5.0, 10.0 and 4.0 ng/mL. This method was applied to determine the major
carotenoids in human serum samples collected from an elderly care center. A total of 62 samples were measured, and in most cases, bcarotene (17.5-1105.7 ng/mL) was present in the highest amount, followed by lutein (10.6-182.3 ng/mL) and lycopene (0-402 ng/mL).
Key words: carotenoids, human serum, HPLC

INTRODUCTION
In the past decade the role of carotenoids in the prevention of chronic diseases such as bladder cancer and
prostate cancer has received considerable attention(1,2,3).
Because of the presence of long-chain conjugated carboncarbon double bonds, carotenoids have been reported to
exhibit antioxidative activity(4). For instance, b-carotene
may minimize the attack of free radicals to cells during
lipid oxidation through the conversion of a highly reactive
singlet oxygen to a more stable triplet oxygen(5). Although
both b-carotene and lycopene possess the same number of
conjugated double bonds, the antioxidative activity of the
former was shown to be inferior to the latter(6). Apparently
this could be attributed to the greater resonance effect of
lycopene due to the coplanarity of 11 conjugated double
bonds.
Numerous studies have indicated that lycopene may
reduce the risk of bladder cancer (1), prostate cancer (3),
gastric cancer (7) and breast cancer (8). Interestingly, the
serum in HIV-infected patients was found to have a lower
level of lycopene(9). Thus, it is possible to diminish the risk
of chronic diseases by elevating the level of lycopene in
human serum. In addition, the application of lutein in the
treatment of age-related macular degeneration is well documented(10).
In view of the impact of these carotenoids to human
health, a precise method for their simultaneous determination in human serum is important. The concentrations of
lycopene, b -carotene and lutein in human plasma were
found to be about 0.16 ± 0.07, 0.74 ± 0.44 and 0.37 ± 0.14
µmol/L (11) , respectively. However, no information is
available as to the contents of major carotenoids in human
* Author for correspondence. Tel: 886-2-29031111 ext. 3626;
Fax: 886-2-29021215; E-mail: nutr1007@mails.fju.edu.tw

plasma in Taiwan. Most published methods employed a
ternary or binary gradient solvent system to separate
carotenoids in serum. In this study we tried to use an
isocratic binary solvent system to separate the major
carotenoids in the serum. The objective of this study was
to develop a simple and rapid method for the determination
of lutein, b-carotene and lycopene in human serum samples
collected from an elderly care center by HPLC.

MATERIALS AND METHODS
I. Materials
A C18 column (Hypersil 5-19626 : 150 ¥ 4.6 mm i.d.,
5 µm particle) was purchased from Thermo Electron Co.
(Bellefonte, PA, USA) and a C30 column (YMCRP 30: 250
¥ 4.6 mm i.d., 5 µm particle) was from Waters Corp. (MA,
USA). All-trans-lycopene standard was from Extrasynthese
Co. (France), all-trans-lutein and all-trans- b -carotene
standards were from Sigma Co. (St. Louis, MO, USA).
The HPLC-grade solvents, including methanol, acetonitrile,
methylene chloride, butanol, and hexane were obtained
from Mallinckrodt Co. (Paris, Ky, USA). Deionized water
was prepared from a Milli-Q water purification system
(Millipore Co., Bedford, MA, USA).
II. Instrumentation
The HPLC system is composed of a Phenomenex DG440 degasser (Phenomenex Co., Torrance, CA, USA), a
Rheodyne model 7161 injector (Rheodyne Co., CA, USA),
an Agilent model 1100 pump (Agilent Co., CA, USA), an
Agilent model 1100 UV-VIS detector and a Jasco MD-915
photodiode-array detector (Tokyo, Japan). A Chem-station
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software was used to process data. The N-1 rotary evaporator was from Eyela Co. (Tokyo, Japan). The 2210R-DTH
supersonic shaker was from Branson Co. (Danbury, CA,
USA). The Sorvall RCSC high-speed centrifuge was from
Du Pont Co. (Wilmington, DL, USA).

sion equations: y = 54.058x-0.2314 for lutein, y = 108.34 x
+ 0.372 for b -carotene and y = 152.83 x - 1.1421 for
lycopene, where y denotes peak area and x denotes concentration. Duplicate analyses were carried out and the data
were expressed as means ± standard deviations.

III. Extraction of Carotenoids in Human Serum

V. Recovery Study

The blood samples were collected from an elderly care
center located in the suburb of Taipei. A total of 62
samples were collected, transported to the laboratory immediately on the same day, and serum was separated and
stored in a freezer (-70˚C) until use. A method similar to
that described by Talwar et al.(12) was used for extraction of
carotenoids from serum. Two-hundred µL serum was
placed in a centrifuge tube. One mL of distilled water and
70 µL of ethanol solution containing 0.01% ascorbic acid
were added for the precipitation of protein and protection of
carotenoids. Two mL hexane was added for the extraction
of carotenoids, and the mixture was centrifuged at 2500
rpm for 20 min, after which the hexane layer was collected
and evaporated to dryness under nitrogen. The residue was
dissolved in 100 µL of methylene chloride/methanol
(45:55, v/v) and filtered through a 0.2 µm membrane filter.
Twenty µL was injected into HPLC.

Human serum was spiked with 20 µL of combined
carotenoid standards with a concentration of 20 ng/mL
each. The spiked serum was then extracted as described
above. After HPLC analysis, the recovery of each major
carotenoid was obtained by dividing the calculated concentration by the added concentration. Triplicate analyses
were performed and the mean value was determined.

RESULTS AND DISCUSSION
I. Extraction of Carotenoids in Human Serum
The extraction method used in this study is simple and
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Various binary and ternary solvent systems were
compared with respect to the separation efficiency of lutein,
b-carotene and lycopene. Two binary solvent systems in
different proportions, including methanol/methylene
chloride (99:1, 97:3 and 95:5, v/v) and water/acetonitrile
(5:95, 10:90 and 20:80, v/v) were used. Likewise, two
ternary solvent systems in different proportions, including
n-butanol/acetonitrile/methylene chloride (30:70:10, v/v/v)
and iso-butanol/acetonitrile/methylene chloride (25:70:5,
25:70:10 and 25:70:20, v/v/v) were used. The solvent
strength of each mobile phase was carefully controlled by
calculating the polarity index. Two analytical columns C18
and C30 were used for comparison. The flow rate was 0.8
mL/min and column temperature was 25˚C with detection
at 476 nm and sensitivity at 0.005 AUFS. The major
carotenoids, lutein, b -carotene and lycopene in serum
samples were identified by comparing the retention times
and absorption spectra of unknown peaks with reference
standards and cochromatography with added standards.
Because of the absence of a suitable internal standard, the
major carotenoids were quantified using absolute calibration curves. Five concentrations ranging 0-1.0 µg/mL were
prepared for lutein, b -carotene and lycopene. After
injection into HPLC, the calibration curve of each
carotenoid was made by plotting peak area against concentration. High correlation coefficients (R2) were found for
lutein, b-carotene and lycopene, which reached to 0.9998,
0.9992 and 0.9990, respectively (Figure 1). The amounts
of carotenoids were calculated from the following regres-
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IV. HPLC Analysis of Carotenoids in Human Serum
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Figure 1. Standard calibration curves of lutein, b-carotene and
lycopene.
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Initially 2 types of columns and various binary and
ternary solvent systems were compared with respect to the
separation efficiency of lutein, b-carotene and lycopene in
human serum. With an appropriate mobile phase, both C18
and C30 columns could provide good separation of these
carotenoids. However, the latter resulted in a much longer
retention time (>50 min) than the former. This could be
attributed to a greater hydrophobic interaction between C30
stationary phase and the major carotenoids, as reported by
Tai and Chen(14). Thus, a C18 column was selected instead
of a C30 column, and the retention time could be drastically
reduced from 50 to 20 min. The most appropriate mobile
phase for a C18 column was found to be methanol/
methylene chloride (95:5,v/v) with sample solvent
methanol/methylene chloride (45:55, v/v). This binary

7.900

II. Separation of Carotenoids in Human Serum

solvent system was able to separate lutein, b-carotene and
lycopene standards within 20 min (Figure 2). Several
minor peaks were also shown on the HPLC chromatogram,
which may be due to the presence of carotenoid isomers.
Figure 3 shows the HPLC chromatogram of major
carotenoids in human serum. Lutein, b-carotene and
lycopene were identified based on the criteria described in
the method section. Likewise, several unknown peaks were
present, which were not identified because of the absence
of commercial standards of carotenoid isomers. An
adequate resolution was observed for lutein, lycopene and
b-carotene, and the retention times were 3.1, 17.5 and 19.9
min, respectively. Talwar et al.(12) developed a mobile
phase of methanol/acetonitrile/tetrahydrofuran (75:20:5,
v/v/v) containing 0.01% ascorbic acid to separate lutein, bcarotene and lycopene within 16 min. However, this
solvent system failed to resolve the major carotenoids in
human serum in our study, probably because of differences
in column length and internal diameter, as well as flow rate
and the variety of sample. Also, the ternary solvent system
employed is more complicated than the binary solvent
system used in our study. In addition, the authors(12) used
450 nm to detect the major carotenoids, which may underestimate the level of lycopene because of a lower response
when compared to lutein or b-carotene. As lycopene has
been proven to be a more important biological compound
than lutein or b-carotene, the amount of lycopene has to be
accurately quantified. Thus, in this study the detection
wavelength was changed to 476 nm for the simultaneous
determination of lycopene, lutein and b-carotene. With the
methods of Milne and Botnen(15) and Thurnham et al.(16),
no lutein was separated and lycopene was difficult to
quantify because of its instability to form cis isomers.
Several authors also applied gradient solvent systems to
separate the major carotenoids in plasma. However, these
methods are either lengthy or complicated when compared
to isocratic solvent system(17,18).

2.462

rapid, which requires 20 min for complete extraction of
carotenoids. Ascorbic acid was added to the extraction
solvent because it has been reported that it could minimize
isomerization and oxidation loss of carotenoids during
extraction and subsequent evaporation (12) . A sample
solvent of methylene chloride/methanol (45:55, v/v) was
used to dissolve the residue. According to a study by Chen
and Chen (13) , an appropriate sample solvent has to be
selected carefully because it may change the polarity of
mobile phase and thus affect the separation efficiency of
carotenoids. The extraction efficiency was accomplished
by a high recovery, which reached to 92, 90 and 87 % for
lutein, b-carotene and lycopene, respectively. These results
were similar to a report by Talwar et al.(12), who also used
ethanol and hexane for extraction of carotenoids and the
recoveries for lutein, b-carotene and lycopene were 94, 87
and 89%, respectively. Apparently the addition of ascorbic
acid to the extraction solvent could enhance the extraction
efficiency greatly.
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Figure 2. HPLC chromatogram of carotenoid standards.
Chromatographic conditions were described in text. Peaks: 1. lutein;
2. lycopene; 3. b-carotene.
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Figure 3. HPLC chromatogram of carotenoids in a human serum
sample. Chromatographic conditions were described in text. Peaks: 1.
lutein; 2. lycopene; 3. b-carotene.

82
Journal of Food and Drug Analysis, Vol. 12, No. 1, 2004

III. Quality Control
The detection limits for lutein, b-carotene and
lycopene were 5.0, 10.0 and 4.0 ng/mL, respectively, based
on a ratio of signal to noise which is higher than 3.
Lycopene was shown to exhibit the lowest detection limit
mainly because a higher response was obtained with
detection at 476 nm when compared to lutein and b carotene. For repeatability and reproducibility test, 1 ppm
each of lutein, b-carotene and lycopene were injected into
HPLC 3 times on the same day and 6 times a week for a
total of 4 weeks. The coefficients of variation (CV %) of
the intra-day variabilities for lutein, b -carotene and
lycopene were 1.87, 1.54 and 2.36%, respectively, while the
inter-day variabilities were 3.21, 3.56 and 4.78 %.
IV. Concentration of Carotenoids in Human Serum
Table 1 shows the quantitative data of major
carotenoids in human serum samples. In most samples, bcarotene showed higher concentrations, whereas both lutein
and lycopene showed lower concentrations. Also, a greater
range of b-carotene level was found. For example, the
highest b-carotene concentration was 1105.7 ng/mL (2.06
µmol/L) while the lowest was 17.5 ng/mL (0.03 µmol/L).
For lutein and lycopene, the levels ranged from 10.6-182.3
ng/mL (0.02-0.32 µmol/L) and 0-402 ng/mL (0-0.75
µmol/L), respectively. A large variation existed probably
because of difference in diet pattern and absorption of the
individual carotenoid. Nevertheless, the mean concentrations of the major carotenoids analyzed in this study were
close to those reported by Watzl et al.(11), who found that
the levels of b-carotene, lutein and lycopene in the human
plasma were 0.74, 0.37 and 0.16 µmol/L, respectively. As
lycopene was reported to possess a higher antioxidative
activity than lutein or b-carotene, the diet pattern for the
elderly has to be modified so that the lycopene level in the
serum can be elevated for those containing low contents of
lycopene. It has been well established that lycopene is the
dominate carotenoid in human serum(19,20). However, in
this study this phenomenon was not observed, probably
because the tomatoes consumed in the diet by the elderly
were not adequately processed. Several reports have
demonstrated that the consumption of adequately processed
tomatoes such as tomato juice could enhance lycopene
bioavailability because more lycopene could be released
from the cell matrix of tomatoes(21). Dietary supplementation with tomato juice was found to increase plasma
lycopene significantly, whereas it remained unchanged for
those consuming raw tomatoes (20). Although lycopene
possesses no provitamin A activity, it shows other vital biological properties and is superior to b-carotene in terms of
suppression of proliferation of cancer cells(22). Watzl et
al.(11) conducted a human intervention study to determine
the effect of consumption of carotenoid-rich vegetables on
the immune system and found that a low-carotenoid diet
reduces T-lymphocyte functions, and addition of tomato

Table 1. Concentrations of carotenoids in human serum samples
Concentration (ng/mL)a
Sample No
Lutein
b-Carotene
Lycopene
1
18.1 ± 1.2
209.2 ± 1.7
52.1 ± 1.0
2
31.8 ± 1.0
291.0 ± 1.0
62.0 ± 0.5
3
15.2 ± 0.3
1105.7 ± 8.2
25.8 ± 0.7
4
21.8 ± 0.6
47.6 ± 0.9
12.0 ± 0.5
5
12.9 ± 0.2
54.7 ± 3.2
13.5 ± 0.4
6
19.0 ± 0.3
50.1 ± 3.1
22.8 ± 1.0
7
35.1 ± 2.3
64.3 ± 2.3
10.2 ± 0.5
8
17.1 ± 2.0
68.8 ± 4.1
20.9 ± 1.7
9
21.7 ± 2.0
77.7 ± 0.6
19.5 ± 0.8
10
37.3 ± 1.4
88.4 ± 0.2
21.6 ± 0.3
11
29.8 ± 1.4
144.5 ± 4.6
15.7 ± 0.6
12
30.8 ± 0.5
128.5 ± 1.3
10.4 ± 0.2
13
41.7 ± 0.3
155.4 ± 3.0
22.6 ± 0.8
14
182.3 ± 3.6
207.2 ± 3.9
26.9 ± 0.7
15
31.9 ± 1.6
136.5 ± 1.2
44.5 ± 0.9
16
33.3 ± 0.2
123.6 ± 3.1
193.4 ± 0.5
17
10.9 ± 0.5
18.0 ± 0.2
13.1 ± 0.1
18
10.6 ± 0.2
30.4 ± 1.3
8.0 ± 0.2
19
39.3 ± 0.7
83.1 ± 3.0
16.0 ± 0.6
20
32.6 ± 0.5
78.3 ± 0.7
8.1 ± 0.2
21
18.9 ± 1.0
67.7 ± 1.0
12.4 ± 0.5
22
15.3 ± 0.3
98.8 ± 0.7
43.7 ± 0.6
23
32.4 ± 0.3
182.1 ± 2.3
62.6 ± 1.2
24
22.0 ± 1.0
190.6 ± 3.6
22.4 ± 0.6
25
50.9 ± 2.5
166.5 ± 1.1
402.0 ± 1.1
26
31.7 ± 0.3
145.3 ± 0.3
21.6 ± 0.3
27
16.2 ± 0.3
41.5 ± 0.5
22.7 ± 0.2
28
24.1 ± 0.3
130.0 ± 0.7
13.9 ± 0.2
29
31.0 ± 0.7
188.6 ± 0.5
78.1 ± 0.7
30
29.1 ± 0.7
63.8 ± 1.2
NDb
31
23.6 ± 0.3
40.1 ± 0.2
5.7 ± 0.4
32
54.2 ± 4.9
341.8 ± 0.9
57.7 ± 0.9
33
32.6 ± 2.3
69.7 ± 0.9
24.6 ± 0.5
34
62.1 ± 3.5
113.1 ± 9.4
112.3 ± 1.6
35
13.8 ± 2.6
24.8 ± 2.1
11.0 ± 1.0
36
67.1 ± 0.7
228.5 ± 3.7
40.7 ± 2.4
37
25.4 ± 4.4
151.0 ± 2.1
87.2 ± 1.7
38
64.1 ± 1.8
22.5 ± 0.3
14.3 ± 0.2
39
71.5 ± 1.4
213.7 ± 9.2
27.8 ± 2.5
40
15.9 ± 1.4
73.1 ± 1.3
35.0 ± 1.4
41
124.5 ± 2.6
144.2 ± 2.2
46.0 ± 1.8
42
32.6 ± 2.3
89.4 ± 1.4
10.3 ± 0.6
43
24.9 ± 5.0
149.1 ± 1.4
42.6 ± 1.7
44
13.6 ± 0.9
129.6 ± 11.6
44.6 ± 0.5
45
29.4 ± 0.5
63.8 ± 1.7
5.3 ± 0.6
46
22.0 ± 0.5
43.1 ± 0.6
33.4 ± 1.4
47
29.9 ± 1.9
32.4 ± 3.8
81.4 ± 1.8
48
14.1 ± 1.0
29.6 ± 4.5
8.0 ± 0.6
49
17.1 ± 0.2
57.0 ± 0.6
10 ± 0.4
50
11.3 ± 0.5
24.1 ± 0.3
14.9 ± 0.6
51
ND
17.5 ± 0.5
ND
52
44.5 ± 1.2
51.8 ± 0.7
17.3 ± 0.2
53
33.1 ± 4.5
58.5 ± 1.3
103.5 ± 2.2
54
17.4 ± 0.5
28.0 ± 0.5
11.1 ± 0.9
55
22.4 ± 0.9
66.0 ± 1.8
6.5 ± 0.2
56
45.6 ± 1.4
257.4 ± 0.5
98.5 ± 1.5
57
23.6 ± 0.7
140.0 ± 1.0
100.3 ± 1.1
58
11.8 ± 0.5
61.9 ± 1.6
29.1 ± 1.2
59
50.7 ± 1.4
114.3 ± 0.9
32.8 ± 1.1
60
22.7 ± 1.2
147.6 ± 1.2
59.4 ± 2.5
61
29.9 ± 1.0
130.3 ± 2.9
58.3 ± 0.8
62
19.4 ± 2.1
114.2 ± 2.2
32.3 ± 1.3
a
Average of duplicate analyses ± standard deviation.
b
ND: not detected.
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juice restores these functions. In another study, Watzl et
al. (23) further demonstrated that after consumption of
tomato juice for 8 weeks, the concentrations of lycopene
and b-carotene increased by 0.36 and 0.31 µmol/L, respectively. In contrast, the level of lutein decreased by 0.07
µmol/L. This result clearly demonstrates that a lycopenerich diet is crucial to enhance immune response of the
elderly. Further research is necessary to study the distribution of various carotenoids in tissues of human body.
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